Stephen Ellis, M.D., professor of medicine and director of interventional cardiology at Cleveland Clinic, discusses the ...
March 30, 2017 — New late-breaking featured clinical research presented today adds strong clinical support for Abbott's ...
March 21, 2017 — In the late-breaking ABSORB III Trial two year results presented at the American College of Cardiology ...
February 2, 2017 — Abbott announced U.S. Food and Drug Administration (FDA) approval for magnetic resonance (MR) ...
January 16, 2017 – In 2015, researchers and physicians at the Minneapolis Heart Institute Foundation (MHIF) were the ...
The biggest news from the 2016 Transcatheter Cardiovascular Therapeutics (TCT) meeting this past fall was the results of ...
January 9, 2017 — The U.S. Food and Drug Administration (FDA) issued a safety communication today concerning patient ...
January 5, 2017 — Abbott announced it completed the acquisition of St. Jude Medical Inc. The transaction provides Abbott ...
December 7, 2016 — Abbott has filed a complaint to terminate its proposed acquisition of Alere based on the substantial ...
Juan Granada, M.D., executive director and chief scientific officer of the Cardiovascular Research Foundation's Skirball ...